Tag:
Latest Headlines
Interim FDA Commissioner Frank Torti ( photo ) wants his employees to zip their lips. According to In Vivo, Torti sent out a memo last Friday telling FDAers that they need to keep proprietary
President Obama used his weekly address to appoint the regulatory duo we've been expecting for more than a week: Margaret "Peggy" Hamburg ( photo ) as PDA commissioner and Joshua Sharfstein ( photo ) as
As expected, President Barack Obama named former New York health commissioner Margaret Hamburg ( photo ) as the new head of the FDA. And he picked Baltimore health commissioner Joshua Sharfstein (
Want to know more about Margaret "Peggy" Hamburg ( photo ), your presumptive FDA commissioner? Wall Street Journal Health Blog has a quick bio, and Time has compiled an executive summary of facts and
The Obama administration is going outside the FDA for its new leaders. Obama has settled on former New York health commissioner Margaret A. Hamburg ( photo ) as the new head of the FDA, sources tell
The word on leadership at FDA is solidifying: The Wall Street Journal confirms with its own sources that former New York health commissioner Margaret "Peggy" Hamburg will be tapped to top the agency,
Word on the street says the White House is close to naming former New York City Health Commissioner Margaret Hamburg ( photo ) as FDA chief. Baltimore Health Commissioner Joshua Sharfstein (
It's no secret that the knives are out in Washington for the FDA. There's just been too much bad publicity for the agency over the last few years. From drug safety snafus dating as far back as Vioxx
Just when the FDA is getting plenty of criticism for lackluster oversight of food and drugs, it could be facing a new challenge: regulating tobacco. The House Committee on Energy and Commerce is set
AIG may be grabbing the boldface headlines today, but another acronym occupies us today: HHS. We finally have our new nominee for Health and Human Services, and as expected, it's Kansas Gov. Kathleen
Press Releases
- Impax Laboratories Inc. - Impax Board of Directors Establishes Compliance Committee
- Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility
- Cancer Genetics to Attend ASCO Annual Meeting
- NPS Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of its Common Stock
- INTERLEUKIN GENETICS ANNOUNCES $12 MILLION PRIVATE PLACEMENT
- More Press Releases
Featured Jobs
-
Import/Export Specialist Job
Celgene Corporation - Basking Ridge NJ US -
Associate Manager, Commercial Specs – Global Reg CMC Job
Celgene Corporation - Basking Ridge NJ US -
Senior Manager, QA Global Training Job
Celgene Corporation - Summit NJ US -
Principal Scientist - Biochemistry
Syros Pharmaceuticals - Watertown Massachusetts -
Principal Scientist - Biochemistry
Syros Pharmaceuticals -
Sponsored Links

